Replies to post #18261 on Aethlon Medical Inc (AEMD)

[oxnous]

Appreciate your post here, jesse. As a veteran of biotech investing, you probably have leaned a lot--false starts, disappointing clinical trial results, and promising treatments flying under the radar.

The US has the most advanced biotech research because of our ability to raise capital on the public markets for these unproven (as of yet) treatments.

Orphan drugs are not abandoned in the US. They can find a way on to the market with the assistance of the FDA if given the chance to prove their efficacy.

I, too, tend towards biotechs in my higher risk portion of my portfolio. Just like to read the data, trade the swings and hold a core position for he long term if warranted.

[oxnous]

Appreciate your post here, jesse. As a veteran of biotech investing, you probably have leaned a lot--false starts, disappointing clinical trial results, and promising treatments flying under the radar.

The US has the most advanced biotech research because of our ability to raise capital on the public markets for these unproven (as of yet) treatments.

Orphan drugs are not abandoned in the US. They can find a way on to the market with the assistance of the FDA if given the chance to prove their efficacy.

I, too, tend towards biotechs in my higher risk portion of my portfolio. Just like to read the data, trade the swings and hold a core position for he long term if warranted.